More compliance burden for R&D Incentive claimants

Federal Budget papers released by the Australian Government on Tuesday, reveal that R&D tax incentive claimants including SMEs and the start-up sector may be faced with additional compliance burden.

Under the new measures effective July 1 2018, there will be additional funding for enforcement activity allocated to the Tax Office and AusIndustry.

Jack Qi, Director of Tax Services and R&D specialist at William Buck, said whilst at first glance SMEs and start-ups may have been spared the brunt of the tightening of the R&D tax incentive, compliance changes could have the biggest impact.

“Given that such activity has already ramped up in recent years, any further focus will mean it’s more important than ever to prepare robust R&D claims and quality contemporaneous internal documentation that will withstand scrutiny,” he said.

“From a cash flow perspective, we anticipate potential delays in companies receiving their R&D refunds until any review is finalised,” he said.

Qi warned the government against making any more changes to the R&D tax incentive.

“Stability of the incentive is key to instilling the confidence of the business sector to make long term decisions on investment in Australian R&D,” Qi said.

“Once these changes are legislated, we urge the Government to refrain from further tinkering of the R&D tax incentive,” he said.

Dr. Choueiri, Principal and R&D Specialist at William Buck agrees, saying since the introduction of the current R&D Tax Incentive Scheme in the last seven years, there had been a boom in organisations wanting to conduct R&D in Australia.

“News of the benefits of conducting R&D in Australia is only just starting to trickle across the world and specifically to North America and Asia. I’ve personally seen an increased level of awareness and interested to conduct R&D Australia from both these regions over the past 18 months alone,” Choueiri said.

“There’s a real threat that many businesses will go off shore to undertake R&D if measures are tightened further,” she said

“The manufacturing sector is slowly starting to recover after a massive wave of companies moved manufacturing operations to Asia to cut costs. After discovering their entitlements for the R&D tax incentive, they are slowly moving operations back or setting up new ones in Australia,” she said.

Choueiri welcomed other integrity measures including more effective, binding guidance to be released outlining the scope of eligible R&D activities.

“This will give more clarity to claimants who need better guidance in understanding what activities are eligible as well as pose less financial risk to their business,” she said.
ENDS

Keep up-to-date with our latest press releases

Fact sheet | overview of the key changes affecting claimants

For companies with turnover below $20 million, the R&D offset will be a premium of 13.5 percentage points above its corporate tax rate. Currently, such companies receive a flat 43.5% incentive.

The new rules will link the R&D incentive rate with the company’s tax rate, which, if proposed legislation is passed, could be 30% or 27.5% depending on its characteristics. It is expected the rate will progressively reduce to 25% by 2026.

Accordingly, some companies could see a reduction in the R&D tax incentive from 43.5% to 41% of eligible expenditure.

Also, perversely, this could see some pre-revenue companies receive a lower R&D incentive than a similar company deriving “passive” income. We anticipate there will be calls for this anomaly to be addressed before legislation is passed.

Cash refunds from the refundable R&D tax offset will be capped at $4 million p.a. (except clinical trials). Any unrefunded amount will be carried forward as a non-refundable tax offset. Whilst this represents a tightening of the R&D tax incentive, this will not impact on the vast majority of SMEs and tech start-ups.

Enforcement & integrity measures

These measures will include:

  • Greater funding will be allocated to enforcement activity by the Tax Office and AusIndustry
  • More effective, binding guidance will be released outlining the scope of what is “eligible R&D”
  • R&D claimant details will be publicly disclosed, along with the amount of R&D expenditure claimed
  • Anti-avoidance rules in the tax law will be strengthened

Changes affecting large businesses
Currently, companies with an annual turnover of $20 million or more are entitled to a non-refundable tax offset of 38.5% of eligible R&D expenditure.

The proposed measures will introduce an “R&D intensity percentage” to calculate the tax offset as a proportion of the company’s R&D expenditure to total expenditure.

Depending on the company’s corporate tax rate, the R&D tax offset is proposed to be:

  • 31.5% or 34% offset if R&D intensity percentage is between 0% and 2%
  • 34% or 36.5% offset if R&D intensity percentage is between 2% and 5%
  • 36.5% or 39% offset if R&D intensity percentage is between 5% and 10%
  • 40% or 42.5% offset if more than 10% of total expenditure relates to R&D

Companies with R&D activities making up a greater portion of their overall business are more likely to benefit from these measures – this will be good news for some. However, companies with greater capital spend (such as manufacturing) may suffer.

Further, the maximum amount of eligible R&D expenditure that can be claimed under the scheme is proposed to increase from $100 million to $150 million per annum – this will be welcomed by large claimants.